St. Jude Medical, Inc.  

(Public, NYSE:STJ)   Watch this stock  
Find more results for Daniel J. Starks
67.07
0.00 (0.00%)
Jul 21 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week 49.94 - 71.90
Open     -
Vol / Avg. 0.00/1.71M
Mkt cap 19.05B
P/E 21.58
Div/yield 0.27/1.61
EPS 3.11
Shares 284.08M
Beta 1.20
Inst. own 85%
Oct 14, 2014
Q3 2014 St. Jude Medical Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Jul 16, 2014
Q2 2014 St. Jude Medical, Inc. Earnings Release
Jul 16, 2014
Q2 2014 St. Jude Medical Inc Earnings Call
Jun 11, 2014
St. Jude Medical Inc at Goldman Sachs Healthcare Conference
May 13, 2014
St. Jude Medical, Inc. at Bank of America Merrill Lynch Health Care Conference
May 1, 2014
St. Jude Medical, Inc. Annual Shareholder Meeting
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 16.99% 12.58%
Operating margin 19.96% 19.11%
EBITD margin - 23.67%
Return on average assets 9.52% 7.09%
Return on average equity 26.74% 17.37%
Employees 16,000 -
CDP Score - -

Address

ONE ST JUDE MEDICAL DRIVE
ST. PAUL, MN 55117
United States - Map
+1-651-7562000 (Phone)
+1-651-7563301 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

St. Jude Medical, Inc. (St. Jude) develops, manufactures and distributes cardiovascular medical devices. Its principal products in each therapy area are: Cardiac Rhythm Management - tachycardia implantable cardioverter defibrillator systems (ICDs) and bradycardia pacemaker systems (pacemakers); Cardiovascular - vascular products, which include vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, vascular plugs and other vascular accessories, and structural heart products, which include heart valve replacement and repair products and structural heart defect devices; Atrial Fibrillation - electrophysiology (EP) introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems, and Neuromodulation - neurostimulation products. On May 30, 2014, the Company acquired CardioMEMS Inc, developer of the CardioMEMS HF System.Effective June 2, 2014, the Company acquired a 19% interest in CardioMEMS.

Officers and directors

Daniel J. Starks Chairman of the Board, President, Chief Executive Officer
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Donald J. Zurbay Chief Financial Officer, Vice President - Finance
Age: 46
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Joel D. Becker President - Americas Division
Age: 46
Bio & Compensation  - Reuters
Eric S. Fain M.D. Group President - St. Jude Medical
Age: 53
Bio & Compensation  - Reuters
Denis M. Gestin President - International
Age: 50
Bio & Compensation  - Reuters
Michael T. Rousseau Chief Operating Officer
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
John C. Heinmiller Executive Vice President
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mark W. Murphy Vice President - Information Technology, Chief Information Officer
Age: 45
Bio & Compensation  - Reuters
Lisa M. Andrade Chief Marketing Officer, Vice President
Age: 42
Bio & Compensation  - Reuters
Scott P. Thome Vice President - Global Operations and Supply Chain
Age: 51
Bio & Compensation  - Reuters